Acer Therapeutics Inc (NASDAQ:ACER)

18.99
Delayed Data
As of Apr 24
 -0.22 / -1.15%
Today’s Change
5.70
Today|||52-Week Range
22.63
+37.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line-926.3K-678.2K-8.4M-4.2M
 
 
 
 
 
Depreciation0.000.002.7K1.3K
 
 
 
Total Other Cash Flow48.3K48.3K285.9K282.6K
 
 
 
 
 
Funds From Operations-878.0K-629.9K-8.1M-3.9M
 
 
 
 
 
Funds From/For Other Operating Expenses143.2K303.1K-152.7K276.3K
 
 
 
 
 
Net Cash Flow - Operating Activities-1.0M-933.0K-7.9M-4.2M
 
 
 
 
 
 
InvestingCapital Expenditures-------60.3K
 
 
Fixed Asset Disposal50.0K0.00980.1K0.00
 
 
 
Net Cash Flow Investing50.0K0.00977.6K-60.3K
 
 
 
 
 
FinancingShort Term Borrowings-64.8K-65.3K5.6M-5.5M
 
 
 
 
 
Long Term Borrowings0.000.00-68.5K5.5M
 
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale413.7K0.009.6M11.5M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing348.9K-65.3K15.1M11.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-622.3K-998.3K8.2M7.2M